The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-881

Absolutely Brilliant ,, Great Find Quiltman , if i could give you more GA I would

Patient Testimonial
“I feel that the monepantel may have slowed my neurological deterioration,” said a MEND participant in the high-dose group. “My dosage was increased to 6 [mg/kg] several days ago. There appears to be no side effects with it.”

from Thurn
To know that we have potentially prolonged the lives of 12 patients [in this trial] is extremely satisfying and humbling.

That is exactly the type of article that was required pre open on the Wednesday the morning after the Positive Phase I Data was announced .Comprehensive and well written engaging Editorial ..

https://alsnewstoday.com/news/vet-drug-monepantel-slows-als-mnd-disease-progression-trial/